Company profile
Evommune, Inc. Insider Trading
EVMNEvery SEC Form 4 insider trading filing for Evommune, Inc. (EVMN) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- NYSE
- Sector
- Pharmaceutical Preparations
- CIK
- 0002044725
- Filings
- 49
- Insiders
- 20
- Last filing
- 2026-07-08
Activity summary
No insider transactions in the last 30 days. The most recent was on July 8, 2026, when Carver Kyle bought 1,000 shares. 49 filings from 20 insiders are on record below.
Quarterly balance
Buy and sell value by quarter, Q4 25 to Q3 26. Evommune, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $70.0M.
90 day insight
Over the last 90 days, Evommune, Inc. insiders bought $146K across 5 transactions with no open-market sales.
- Most active insider: Patel Jeegar Pravinkumar with 6 transactions totaling $471K.
- Largest single sale: $453K by Drew Janice Suzann on Jun 22, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Carver Kyle | EVMN | Purchase | 1,000 | $13.26 | $13K |
| Jul 7, 2026 | Kirsch Arthur S | EVMN | Purchase | 10,000 | $13.30 | $133K |
| Jun 22, 2026 | Drew Janice Suzann | EVMN | Option Exercise10b5 | 3,839 | — | — |
| Jun 22, 2026 | Pena Luis C. | EVMN | Sale10b5 | 7,438 | $22.71 | $169K |
| Jun 22, 2026 | Drew Janice Suzann | EVMN | Sale10b5 | 20,000 | $22.63 | $453K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=EVMN" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Evommune, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →